Comparison of LPS and MS-induced depressive mouse model: behavior, inflammation and biochemical changes. 2022

Xiaojin Yu, and Hui Yao, and Xiaohui Zhang, and Lulu Liu, and Shuangmei Liu, and Youjing Dong
Department of Anesthesiology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Shenyang, Liaoning, 110004, P. R. China. yuxj_cmu@foxmail.com.

Depression is a mental disease involving complex pathophysiological mechanisms, and there are many ways to establish depressive mouse models. The purpose of this study is to comprehensively compare the behavioral changes and its mechanism induced by two different models. This study established two depressive mouse models by maternal separation (MS) or lipopolysaccharide (LPS) administration, and added fluoxetine treatment group respectively for comparison. MS induced more apparent anxiety-like behavior while LPS induced more apparent depressive-like behavior. LPS increased peripheral inflammatory factors more apparent, which were mitigated by fluoxetine. MS inhibited the 5-HT system more obviously and was relieved by fluoxetine. LPS triggered stronger immune response in the hippocampus and prefrontal cortex (PFC). MS significantly reduced the expression of neurotrophic proteins and was alleviated by fluoxetine. Overall, LPS induced stronger system inflammation, while MS impaired the function of HPA axis and 5-HT system. Our results will contribute to a deeper understanding of the pathophysiology of different stress-induced depression and will also help researchers select appropriate models of depression for their own needs.

UI MeSH Term Description Entries
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008426 Maternal Deprivation Prolonged separation of the offspring from the mother. Deprivation, Maternal,Deprivations, Maternal,Maternal Deprivations
D010913 Pituitary-Adrenal System The interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary. Pituitary Adrenal System,Pituitary-Adrenal Systems,System, Pituitary-Adrenal,Systems, Pituitary-Adrenal
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005473 Fluoxetine The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. Fluoxetin,Fluoxetine Hydrochloride,Lilly-110140,N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,Prozac,Sarafem,Lilly 110140,Lilly110140
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Xiaojin Yu, and Hui Yao, and Xiaohui Zhang, and Lulu Liu, and Shuangmei Liu, and Youjing Dong
March 2015, Neuroscience letters,
Xiaojin Yu, and Hui Yao, and Xiaohui Zhang, and Lulu Liu, and Shuangmei Liu, and Youjing Dong
November 2020, Brain, behavior, and immunity,
Xiaojin Yu, and Hui Yao, and Xiaohui Zhang, and Lulu Liu, and Shuangmei Liu, and Youjing Dong
March 2023, International immunopharmacology,
Xiaojin Yu, and Hui Yao, and Xiaohui Zhang, and Lulu Liu, and Shuangmei Liu, and Youjing Dong
April 2001, Physiological genomics,
Xiaojin Yu, and Hui Yao, and Xiaohui Zhang, and Lulu Liu, and Shuangmei Liu, and Youjing Dong
April 2022, Behavioural brain research,
Xiaojin Yu, and Hui Yao, and Xiaohui Zhang, and Lulu Liu, and Shuangmei Liu, and Youjing Dong
March 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Xiaojin Yu, and Hui Yao, and Xiaohui Zhang, and Lulu Liu, and Shuangmei Liu, and Youjing Dong
February 2022, Neuroscience letters,
Xiaojin Yu, and Hui Yao, and Xiaohui Zhang, and Lulu Liu, and Shuangmei Liu, and Youjing Dong
September 2018, Glia,
Xiaojin Yu, and Hui Yao, and Xiaohui Zhang, and Lulu Liu, and Shuangmei Liu, and Youjing Dong
January 2016, PloS one,
Xiaojin Yu, and Hui Yao, and Xiaohui Zhang, and Lulu Liu, and Shuangmei Liu, and Youjing Dong
February 2023, Journal of Zhejiang University. Science. B,
Copied contents to your clipboard!